SCHEMBL24202082

SCHEMBL24202082

COc1cc(N2CCNCC2)cc(C)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB1 P08588 5/20 0.57
CHRNB2 P17787 2/20 0.54
CHRNA4 P43681 2/20 0.54
HTR7 P34969 2/20 0.49
HTR1A P08908 1/20 0.49
HTR3E A5X5Y0 4/20 0.49
HTR3B O95264 4/20 0.49
HTR3A P46098 4/20 0.49
HTR3D Q70Z44 4/20 0.49
HTR3C Q8WXA8 4/20 0.49
SIGMAR1 Q99720 2/20 0.49
CYP2C19 P33261 2/20 0.46
DRD2 P14416 1/20 0.46
DRD3 P35462 1/20 0.46
HTR6 P50406 1/20 0.46
ACVR1B P36896 2/20 0.46
TGFBR1 P36897 2/20 0.46
ACVR1 Q04771 2/20 0.46
KCNH2 Q12809 2/20 0.46
BMPR1B O00238 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19706020 0.84 ADRB1 (0.54) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL28848369 0.83 ADRB1 (0.53) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL335755 0.81 ADRB1 (0.62) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL7507944 0.81 ADRB1 (0.62) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL10208374 0.80 ADRB1 (0.67) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL27403145 0.80 ADRB1 (0.67) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL19709394 0.79 ADRB1 (0.61) ADRB1CHRNB2CHRNA4HTR7HTR1A
Hydrochloric Acid SCHEMBL8931722 0.79 ADRB1 (0.61) ADRB1CHRNB2CHRNA4HTR7HTR1A
SCHEMBL19709420 0.79 ADRB1 (0.61) ADRB1CHRNB2CHRNA4HTR7HTR1A
Bromide SCHEMBL10572729 0.79 ADRB1 (0.61) ADRB1CHRNB2CHRNA4HTR7HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3939968-A1 NOVEL COMPOUND HAVING ANTICANCER ACTIVITY, AND METHOD FOR PRODUCING SAME Medicinal Bioconvergence Research Center (KR) 2022-01-19 EP disclosed